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Word count: Abstract 491 words, main text 2174 words. 21 
Condensation 22 
Exercise during pregnancy in normal-weight women is not associated with an increased risk of 23 
preterm birth.  24 
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Abstract  37 
Background: Preterm birth (PTB) is the major cause of perinatal mortality in the United States. 38 
In the past, pregnant women have been recommended against exercise because of presumed risks 39 
of PTB. Physical activity has been theoretically related to PTB as it increases the release 40 
catecholamines, especially norepinephrine, which might stimulate myometrial activity. 41 
Conversely, exercise may reduce the risk of PTB by other mechanisms such as decreased 42 
oxidative stress or improved placenta vascularization. Therefore, the safety of exercise regarding 43 
PTB and its effects on gestational age at delivery remain controversial.  44 
Objective: To evaluate the effects of exercise during pregnancy on the risk of PTB.  45 
Data sources: MEDLINE, EMBASE, Web of Sciences, Scopus, ClinicalTrial.gov, OVID and 46 
Cochrane Library were searched from the inception of each database to April 2016.  47 
Methods of study selection: Selection criteria included only randomized clinical trials (RCTs) 48 
of pregnant women randomized before 23 weeks to an aerobic exercise regimen or not. Types of 49 
participants included women mainly of normal weight with uncomplicated, singleton 50 
pregnancies without any obstetric contraindication to physical activity. The summary measures 51 
were reported as relative risk (RR) or as mean difference (MD) with 95% confidence intervals 52 
(CI). The primary outcome was the incidence of PTB <37weeks. 53 
Tabulation, integration, and results: Of the 2,059 women included in the meta-analysis, 1,022 54 
(49.6%) were randomized to the exercise group and 1,037 (50.4%) to the control group. Aerobic 55 
exercise lasted about 35-90 minutes 3-4 times per week. Women who were randomized to 56 
aerobic exercise had a similar incidence of PTB<37 weeks (4.5% vs 4.4%; RR 1.01, 95% CI 57 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
0.68-1.50) and a similar mean gestational age at delivery (MD 0.05 week, 95% CI - 0.07 to 0.17) 58 
compared to controls. Women in the exercise group had a significantly higher incidence of 59 
vaginal delivery (73.6% vs 67.5%; RR 1.09, 95% CI 1.04-1.15) and significantly lower 60 
incidence of cesarean delivery (17.9% vs 22%; RR 0.82, 95% CI 0.69-0.97) compared to 61 
controls. The incidence of operative vaginal delivery (12.9% vs 16.5%; RR 0.78, 95% CI 0.61-62 
1.01) was similar in both groups. Women in the exercise group had a significantly lower 63 
incidence of gestational diabetes mellitus (2.4% vs 5.9%; RR 0.41, 95% CI 0.24-0.68) and 64 
significantly lower incidence of hypertensive disorders (1.9% vs 5.1%; RR 0.36, 95% CI 0.19-65 
0.69) compared to controls. No differences in low birth weight (5.2% vs 4.7%; RR 1.11, 95% CI 66 
0.72-1.73) and mean birth weight (MD -10.46 grams, 95% CI -47.10 to 26.21) between exercise 67 
group and controls were found. 68 
Conclusion:  Aerobic exercise for 35-90 minutes 3-4 times per week during pregnancy can be 69 
safely performed by normal-weight women with singleton, uncomplicated gestations, as this is 70 
not associated with an increased risk of PTB or with a reduction in mean gestational age at 71 
delivery. Exercise was associated with a significantly higher incidence of vaginal delivery and a 72 
significantly lower incidence of cesarean delivery, with a significantly lower incidence of 73 
gestational diabetes mellitus and hypertensive disorders, and therefore should be encouraged. 74 
 75 
Key words: physical activity, exercise during pregnancy, preterm birth, preterm delivery, 76 
pregnancy outcomes, obstetric outcomes. 77 
 78 
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INTRODUCTION 79 
Preterm birth (PTB) is the major cause of perinatal mortality in  the United States.1 In the past, 80 
pregnant women have been recommended against exercise because of presumed risks of 81 
pregnancy loss and PTB, possibly due to reduced placental circulation.2 Physical activity has 82 
been theoretically related to PTB as it increases the release of catecholamines, especially 83 
norepinephrine, which might stimulate myometrial activity.3 Conversely, exercise may reduce 84 
the risk of PTB by other mechanisms such as decreased oxidative stress or improved placenta 85 
vascularization,4 an adaptive response to intermittent reduction in uterine blood flow, as well as 86 
increased blood volume found in pregnant women during exercise.5 Physical activity during 87 
pregnancy may be decreased due to lack of time, lack of energy, discomfort or pain and concern 88 
about baby’s health.6 In fact, bed rest is commonly recommended in pregnancy.7 Therefore, the 89 
safety of exercise regarding PTB, and its effects on gestational age at delivery, remain 90 
controversial.  91 
Objective 92 
The aim of this systematic review and meta-analysis was to evaluate the effects of exercise 93 
during pregnancy on the risk of PTB. 94 
METHODS 95 
Search strategy 96 
This meta-analysis was performed according to a protocol recommended for systematic review.8 97 
The review protocol was designed a priori defining methods for collecting, extracting and 98 
analyzing data. The research was conducted using MEDLINE, EMBASE, Web of Sciences, 99 
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Scopus, ClinicalTrial.gov, OVID and Cochrane Library as electronic databases. The trials were 100 
identified with the use of a combination of the following text words: “exercise” or “physical 101 
activity” and “pregnancy” and “preterm birth” or “preterm delivery” and “randomized trial” as 102 
publication type, from the inception of each database to April 2016. Review of articles also 103 
included the abstracts of all references retrieved from the search.  104 
Study selection 105 
Selection criteria included only randomized clinical trials (RCTs) of pregnant women 106 
randomized to an exercise regimen or not. We included only RCTs reporting PTB as an 107 
outcome. Types of participants included women with uncomplicated, singleton pregnancies 108 
without any obstetric contraindication to physical activity. In all the trials, the intervention group 109 
participated in planned aerobic exercise. In the control group, women did not participate in 110 
exercise sessions and only attended regular scheduled obstetric visits. When possible, data only 111 
on women with normal body mass index (BMI) (18.5-24.9) were selected. RCTs including only 112 
underweight (BMI≤18.5) or only overweight or obese (BMI ≥25) women, those including diet, 113 
counseling, and/or weight monitoring, and those assessing reduction in exercise, were excluded. 114 
Quasi-randomized trials (i.e. trials in which allocation was done on the basis of a pseudo-random 115 
sequence, e.g. odd/even hospital number or date of birth, alternation) were also excluded.   116 
Data extraction and risk of bias assessment 117 
The risk of bias in each included study was assessed by using the criteria outlined in the 118 
Cochrane Handbook for Systematic Reviews of Interventions.8 Seven domains related to risk of 119 
bias were assessed in each included trial since there is evidence that these issues are associated 120 
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with biased estimates of treatment effect: 1) random sequence generation; 2) allocation 121 
concealment; 3) blinding of participants and personnel; 4) blinding of outcome assessment; 5) 122 
incomplete outcome data; 6) selective reporting; and 7) other bias. Review authors’ judgments 123 
were categorized as “low risk,” “high risk” or “unclear risk” of bias.8 124 
All analyses were done using an intention-to-treat approach, evaluating women according to the 125 
treatment group to which they were randomly allocated in the original trials. The primary 126 
outcome was the incidence of PTB <37weeks. Secondary outcomes were gestational age at 127 
delivery, spontaneous vaginal delivery, operative vaginal delivery, cesarean delivery, gestational 128 
diabetes, hypertensive disorders (defined as gestational hypertension or preeclampsia) and 129 
neonatal outcomes including birth weight and low birth weight (i.e. birth weight <2500 grams). 130 
We assessed the primary outcome (i.e. incidence of PTB <37weeks) in a sensitivity analysis 131 
according to the risk of bias of the included trials;8 and in subgroup analysis according to the type 132 
and length of exercise. 133 
Data analysis 134 
Data analysis was completed using Review Manager 5.3 (Copenhagen: The Nordic Cochrane 135 
Center, Cochrane Collaboration, 2014).8 Statistical heterogeneity between studies was assessed 136 
using the Higgins I2 statistics. In case of statistical significant heterogeneity (I2≥0), the random 137 
effects model of DerSimonian and Laird was used to obtain the pooled risk ratio estimate; 138 
otherwise, in case of no inconsistency in risk estimates (I2=0), a fixed effect model was used.8 139 
The summary measures were reported as relative risk (RR) or as mean difference (MD) with 140 
95% confidence intervals (CI). Potential publication biases were assessed graphically by using 141 
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the funnel plot and statistically by using Begg’s and Egger’s tests. p value < 0.05 was considered 142 
statistically significant.  143 
The meta-analysis was reported following the Preferred Reporting Item for Systematic Reviews 144 
and Meta-analyses (PRISMA) statement.9 Before data extraction, the review was registered with 145 
the PROSPERO International Prospective Register of Systematic Reviews (registration number: 146 
CRD42016037841). 147 
Three authors (DDM, EMM, GS) independently assessed inclusion criteria, risk of bias, data 148 
extraction and data analysis. Disagreements were resolved by discussion with a fourth reviewer 149 
(VB). Data from each eligible study were extracted without modification of original data onto 150 
custom-made data collection forms. Differences were reviewed, and further resolved by common 151 
review of the entire process. Data not presented in the original publications were requested from 152 
the principal investigators. 153 
Results 154 
Study selection and study characteristics  155 
Figure 1 shows the flow diagram (PRISMA template) of information derived from review of 156 
potentially relevant articles. Nine RCTs, including 2,059 sedentary women with an 157 
uncomplicated, singleton pregnancy were included in the meta-analysis.10-18 One study was 158 
published in abstract form only.10  159 
The quality of RCTs included in our meta-analysis was assessed by the Cochrane 160 
Collaboration’s tool.8 All the included studies, except one,10 used a computer-generated table of 161 
random numbers and had low risk of bias in “incomplete outcome data.” No method of blinding 162 
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as to the group allocation was reported (Figure 2). Figure 3 shows the funnel plot for the primary 163 
outcome for assessing publication bias; the symmetric plot suggests no publication bias. 164 
Publication bias, assessed using Begg’s and Egger’s tests, was not significant (P=0.48 and 0.51, 165 
respectively). Unpublished data was kindly provided by an author10 who was contacted by email. 166 
Table 1 shows the characteristics of the included trials. In five trials,12,15-18 women were 167 
randomized during the first trimester; in four studies,10,11,13,14 women were randomized during 168 
the early second trimester (≤22 weeks). Table 2 shows inclusion and exclusion criteria of these 169 
trials. Characteristics of the women included were reported in Table 3. All studies randomized 170 
only sedentary, pregnant women with uncomplicated, singleton gestations. Women were 171 
excluded if any obstetric contraindications, mostly as recommended by ACOG (Table 2).19 In all 172 
nine trials, the intervention group participated in aerobic exercise. Seven trials10,12,14-18 were 173 
toning, resistance and flexibility exercise, together with joint mobilization activities, mostly 174 
according to ACOG recommendations.19 Two trials11,13 were water aerobics. The mean time of 175 
every session was 57 minutes, three times a week in eight trials,11-18 four times a week in one 176 
trial.10  In the control group, women did not participate in any exercise sessions and attended only 177 
regularly scheduled obstetric visits.  178 
Synthesis of results 179 
Of the 2,059 women included in the meta-analysis, 1,022 (49.6%) were randomized to the 180 
exercise group and 1,037 (50.4%) to the control group. The statistical heterogeneity within the 181 
studies was low with no inconsistency (I2=0) for the risk estimates for the primary outcome. 182 
Table 4 shows the pooled data of primary and secondary outcomes of the meta-analysis. 183 
Pregnant women who were randomized before 23 weeks to 35-90 minutes of aerobic exercise 3-184 
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4 times per week for 10 weeks or up to delivery had a similar incidence of PTB<37 weeks (4.5% 185 
vs 4.4%; RR 1.01, 95% CI 0.68-1.50) and a similar mean gestational age at delivery (MD 0.05 186 
week, 95% CI -0.07 to 0.17) compared to controls. Women in the exercise group had a 187 
significantly higher incidence of vaginal delivery (73.6% vs 67.5%; RR 1.09, 95% CI 1.04-1.15) 188 
and significantly lower incidence of cesarean delivery (17.9% vs 22%; RR 0.82, 95% CI 0.69-189 
0.97) compared to controls. The incidence of operative vaginal delivery (12.9% vs 16.5%; RR 190 
0.78, 95% CI 0.61-1.01) was similar in both groups. Women in the exercise group had a 191 
significantly lower incidence of gestational diabetes mellitus (2.4% vs 5.9%; RR 0.41, 95% CI 192 
0.24-0.68) and significantly lower incidence of hypertensive disorders (1.9% vs 5.1%; RR 0.36, 193 
95% CI 0.19-0.69) compared to controls. No differences in low birth weight (5.2% vs 4.7%; RR 194 
1.11, 95% CI 0.72-1.73) and mean birth weight (MD -10.46 grams, 95% CI -47.10 to 26.21) 195 
between exercise group and controls were found. Sensitivity analysis, excluding studies judged 196 
at high risk of bias,10,15,16,18 concur with the overall analysis (RR 0.82, 95% CI 0.42-1.60). 197 
Pooled data from subgroup analyses according to the type of exercise, including trials on water 198 
aerobic exercise (RR 1.25, 95% CI 0.34-4.58);11,13 and according to the length of exercise, 199 
including trials had length of ≥60minutes (RR 0.88, 95% CI 0.44-1.74),10,11,14,16,17 showed no 200 
difference in the primary outcome. 201 
Comment 202 
Main findings 203 
This pooled meta-analysis of nine RCTs including 2,059 women with uncomplicated, singleton 204 
pregnancies showed that exercise during pregnancy in mostly normal-weight women is not 205 
associated with an increased risk of PTB. Exercise during pregnancy is associated with a 206 
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significantly increased incidence of vaginal delivery and significantly decreased incidence of 207 
cesarean delivery, while there is no difference with operative vaginal delivery, compared to 208 
controls. Exercise during pregnancy is also associated with a significantly lower incidence of 209 
gestational diabetes mellitus and hypertensive disorders. 210 
Comparison with existing literature 211 
A 2006 Cochrane review showed that increasing exercise in sedentary pregnant women was 212 
associated with a statistically non-significant increase in the risk of PTB and with a clinically 213 
irrelevant shortening of gestational age at delivery.20 No significant effects on mean birth weight 214 
and on risk of cesarean delivery were found.20 However, only three trials were included. In 2012 215 
another meta-analysis of 44 RCTs including 7,278 pregnant women evaluated diet, exercise and 216 
a mixed approach of these two interventions.21 They found an overall trend towards reduction in 217 
PTB with diet, exercise and/or mixed approach compared to controls.21 The subgroup analysis on 218 
exercise included only 5 RCTs with PTB outcome and no effect was found.21 A 2015 Cochrane 219 
review, evaluating diet or exercise or both during pregnancy showed no difference in PTB 220 
between the intervention and standard care groups.22 The subgroup analysis on exercise included 221 
only 3 RCTs with PTB outcome and also no effect was found.22 A 2015 systematic review of 222 
RCTs demonstrated that structured prenatal exercise did not adversely affect birth weight 223 
compared to standard prenatal care alone.23 224 
 225 
Strengths and limitations 226 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
12 
 
Our study has several strengths. This meta-analysis included all RCTs - nine - published so far 227 
on the topic. These studies in general are of high quality and with a low risk of bias according to 228 
the Cochrane risk of bias tools. To our knowledge, no prior meta-analysis with PTB as a primary 229 
outcome on the issue of exercise during pregnancy is as large, up-to-date or comprehensive. The 230 
statistical heterogeneity within the studies was low. The number of the included women - 2,059 - 231 
was high. In addition, publication bias was not apparent by statistical analysis. These are key 232 
elements that are needed to evaluate the reliability of a meta-analysis.8 233 
Limitations of our study include that the trimester in which exercise was performed, the 234 
adherence to exercise sessions, and the variation in maternal nutritional intake, could all have 235 
influenced outcomes. In only one study,15 outcomes are stratified by pre-pregnancy BMI 236 
categories; while in one study,18 only PTB and low birth weight are stratified by pre-pregnancy 237 
BMI categories. Therefore, while mean BMIs for included women in all randomized studies 238 
were always in the normal range (Table 3), some studies included a minority of underweight, 239 
overweight and obese women, which could not be excluded as their outcomes were not reported 240 
separately. In four studies,12,16-18 27 women already randomized to exercise or not (11 in the 241 
exercise group and 16 in the control group) were excluded from further analyses because they 242 
had preterm labor. Another limitation of this study is that the individual trials differ somewhat in 243 
how they define aerobic exercise, intensity of exercise and time of exercise. Spontaneous PTB 244 
was not reported separately in the trials, except in one trial,17 where iatrogenic PTB was excluded 245 
as an outcome. 246 
Conclusions and implications 247 
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Aerobic exercise for 35-90 minutes 3-4 times per week during pregnancy can be safely 248 
performed by normal-weight women with singleton, uncomplicated gestations, as this is not 249 
associated with an increased risk of PTB or with a reduction in mean gestational age at delivery. 250 
As supported by recent literature,24 exercise was associated with a significantly higher incidence 251 
of vaginal delivery, and significantly lower incidences of cesarean delivery, gestational diabetes, 252 
and hypertensive disorders, and therefore should be encouraged. 253 
Our findings support the ACOG recommendations about exercise during uncomplicated 254 
pregnancies,19 and the U.S. Department of Health and Human Services guidelines for healthy 255 
pregnant and postpartum women that recommend at least 150 minutes of moderate-intensity 256 
activity per week.25 257 
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Table 1. Characteristics of the included trials 341 
 Carpenter, 
199010 
Prevedel, 
200311 
Barakat, 
200812 
Cavalcante, 
200913 
Haakstad, 
201114 
Ruiz, 
201315 
Barakat, 
201416 
Barakat, 
201417 
Barakat, 
201618 
Study Location USA Brazil Spain Brazil Norway Spain Spain Spain Spain 
Sample size* 14 
(7 vs 7) 
41 
(22 vs 19) 
142  
(72 vs 70) 
71  
(34 vs 37) 
105  
(52 vs 53) 
687  
(335 vs 352) 
200  
(107 vs 93) 
290  
(138 vs 152) 
513 
(257 vs 256) 
GA (weeks) at 
randomization 
Mean+SD or 
WR 
20 to 22 16 to 20 12 to 13 16 to 20 17.3±4.1 
vs 
18.0±4.3 
5 to 6 6 to 7** 8 to 10 9 to 11 
Type of exercise 30 min 
physical 
training 
preceded 
and 
followed 
by 30 min 
cycle 
ergometry 
at 60% 
VO2 max. 
Hydrotherapy 
exercises: 
stretching; 
resistance, 
targeted, 
respiratory 
exercises in 
an indoor 
swimming 
pool with 
water at 28-
32°C. 
Stretching; 
toning and 
joint 
mobilization 
exercises; 
resistance 
exercises. 
Water 
aerobics in 
an indoor 
swimming 
pool with 
water at 28-
30°C. 
Aerobic 
dance, 
followed by 
abdominal, 
pelvic floor 
and back 
muscle 
training, 
stretching, 
relaxation 
and body 
awareness 
exercises. 
Aerobic, 
resistance 
and 
stretching 
exercises. 
Walking and 
stretching, 
followed by 
toning and 
joint 
mobilization 
exercises, 
aerobic dance 
and specific 
exercises for 
leg, buttocks 
and abdomen. 
Toning, joint 
mobilization, 
resistance 
exercises 
preceded and 
followed by 
walking and 
light 
stretching. 
Aerobic 
exercise, 
aerobic 
dance, 
muscular 
strength and 
flexibility 
exercises 
preceded by 
walking and 
light 
stretching 
and followed 
by relaxation 
and pelvic 
floor 
exercise.  
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Duration of a 
single session 
(min) 
 
90 
 
60 
 
35 
 
50 
 
60 
 
50-55 
 
55-60 
 
55-60 
 
50-55 
Times per week         
(# days) 
 
4 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
Intensity of 
exercise (HR) 
 
NR NR <80% of 
their age-
predicted 
max HR. 
<70% of 
their age-
predicted 
max HR. 
NR <60% of 
their age-
predicted 
max HR. 
<60% of their 
age-predicted 
max HR. 
<60-75% of 
their age-
predicted 
max HR. 
<70% of 
their age-
predicted 
max HR. 
Self-reported 
intensity of 
exercise (Borg 
scale***) 
NR NR NR NR 12-14 10-12 12-13 NR 12-14 
Control group 10 weeks 
of non-
exercise. 
No 
hydrotherapy 
program. 
No exercise, 
except those 
activities 
necessary 
for daily 
living. 
  No regular 
physical 
activity 
during the 
entire 
pregnancy. 
Women 
were not 
encouraged 
neither 
discouraged 
from 
exercising. 
Regular 
scheduled 
visits, every 
4 to 5 weeks 
until the 35th 
week of GA 
then weekly 
until 
delivery. 
Women 
received 
general 
nutrition 
and physical 
activity 
counseling 
No exercise 
during 
pregnancy. 
NR General 
advice from 
their health 
care provider 
about 
positive 
effects of 
physical 
activity; 
regular 
scheduled 
visits; 
women not 
discouraged 
from 
exercising on 
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and were 
not 
discouraged 
from 
exercising. 
their own 
and asked by 
telephone 
about their 
exercise once 
each 
trimester. 
Primary 
outcome 
Change in 
resting 
heart rate; 
exercise 
stroke 
volume; 
exercise 
VO2; O2 
pulse. 
Maternal 
outcomes: 
body 
composition 
and 
cardiovascular 
capacity; 
Perinatal 
outcomes: 
weight and 
prematurity. 
Healthy 
gravidae 
and GA at 
delivery. 
Evolution of 
pregnancy 
(GA at 
delivery, 
preterm 
birth), 
maternal 
body 
composition 
(weight 
gain, BMI, 
proportion 
of fat mass) 
and 
perinatal 
outcomes 
(Apgar 
score, 
weight at 
birth and 
birth weight 
adequate for 
GA). 
Infant birth 
weight. 
Maternal 
weight gain. 
Maternal (GA, 
preterm birth, 
blood 
pressure, 
weight gain, 
type of 
delivery, 
GDM) and 
fetal (birth 
weight, head 
circumference, 
birth size, 
Apgar score, 
pH of 
umbilical 
cord, gender) 
outcomes. 
GA at 
delivery. 
Gestational 
hypertension. 
Other comments Physical 
training 
--- --- --- In addition 
to joining 
Sample size 
refers to 
--- --- Sample size 
refers to only 
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only 10 
weeks in 
mid-
pregnancy. 
the 
scheduled 
exercise 
sessions, all 
women in 
the exercise 
group were 
asked to 
include 30 
minutes of 
moderate 
self-
imposed 
physical 
activity on 
the 
remaining 
week-days. 
only 
normal-
weight 
women 
included in 
the original 
trial.  
normal-
weight 
women 
included in 
the original 
trial.  
HR, hearth rate; GA, gestational age; BMI, body mass Index; GDM, gestational diabetes mellitus, ACOG, American Congress of Obstetricians 342 
and Gynecologists; NR, not reported 343 
*Data are presented as total number (number in the intervention group vs number in the control group). 344 
**Pregnant women who underwent their first ultrasound examination at 10 to 12 weeks were offered the opportunity to participate, following a 345 
randomization process. 346 
***Borg Scale is a 15 category scale (from 6 to 20) to measure the level of perceived exertion. Light exercise is about 6-11; 13 somewhat hard; 15 347 
hard; 19 extremely hard.  348 
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Table 2. Inclusion and exclusion criteria of the women included in the trials. 349 
 Inclusion criteria Exclusion criteria 
Carpenter, 
199010 
Sedentary, pregnant women. Not Reported. 
Prevedel, 
200311 
Nulliparous with singleton, uncomplicated gestations. Any medical or obstetrical contraindication. 
Barakat, 
200812 
Women with singleton, uncomplicated gestations, not at high 
risk of preterm delivery. 
Any obstetric contraindication to exercise suggested by ACOG; not 
planning to give birth in the same obstetrics hospital department; not to 
be under medical follow-up throughout the entire pregnancy; any 
serious medical condition. 
Cavalcante, 
200913 
Low-risk, sedentary pregnant women with uncomplicated, 
singleton gestations. 
History of two or more cesarean sections; medical conditions 
contraindicating the practice of physical exercise and/or practical 
impediments. 
Haakstad, 
201114 
Nulliparous women with uncomplicated, singleton gestations 
whose pre-pregnancy exercise levels did not include 
participation in a structured exercise program; ability to read, 
understand and speak Norwegian; to be within the first 24 weeks 
of pregnancy. 
History of more than 2 miscarriages, severe heart disease and persistent 
bleeding after 12 weeks of gestation; multiple pregnancy; poorly 
controlled thyroid disease; gestational hypertension or preeclampsia; 
diabetes or gestational diabetes. 
Ruiz, 201315 Sedentary women with singleton, uncomplicated gestations, not 
at high risk of preterm delivery and not participating in any other 
trial. 
Any obstetric contraindication to exercise suggested by ACOG. 
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Barakat, 
201416 
Women with uncomplicated, singleton gestations. Any obstetric contraindication to exercise suggested by ACOG; not 
planning to give birth in the obstetrics department of the study; not 
receiving medical follow-up throughout pregnancy; participating in 
another physical program or having a high level of pre-gestational 
physical exercise. 
Barakat, 
201417 
Women with uncomplicated, singleton gestations. Any obstetric contraindication to exercise suggested by ACOG; not 
planning to give birth in the obstetrics department of the study; not 
receiving medical follow-up throughout pregnancy; participating in 
another physical program or having a high level of pre-gestational 
physical exercise. 
Barakat, 
201618 
Women with uncomplicated, singleton gestations. Any obstetric contraindication to exercise suggested by ACOG; not 
planning to give birth in the obstetrics department of the study; not 
receiving medical follow-up throughout pregnancy; history of risk of 
preterm birth. 
BMI, Body Mass Index; ACOG, American Congress of Obstetricians and Gynecologists 350 
 351 
 352 
 353 
 354 
 355 
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Table 3. Characteristics of the women included in the trials  356 
 Carpenter, 199010 
Prevedel, 
200311 
Barakat, 
200812 
Cavalcante, 
200913 
Haakstad, 
201114 
Ruiz, 
201315 
Barakat, 
201416 
Barakat, 
201417 
Barakat, 
201618 
 
Maternal age (y) 
Mean+SD 
 
NR 
 
20 
30.4±2.9 
vs 
29.5±3.7 
25.8±4.6 
vs 
24.4±5.8 
31.2±3.7 
vs 
30.3±4.4 
31.6±4 
vs 
31.9±4 
31.57±3.87 
vs 
31.51±3.92 
31.4±3.2 
vs 
31.7±4.5 
31.6±4.2 
vs 
31.8±4.5 
Parity 
0 
 
NR 
 
NR 
72.2%  
vs  
57.1% 
47.1%* 
vs 
62.2%* 
NR NR 
60.7% 
vs 
53.9% 
60.9% 
vs 
54.6% 
67.8% 
vs 
59.8% 
1 
 
NR 
 
NR 
22.2% 
vs 
35.7% 
NR NR NR 
34.6% 
vs 
40.4 
33.3% 
vs 
39.5% 
26.2% 
vs 
33.2% 
>1 
 
NR 
 
NR 
5.6% 
vs 
7.2% 
NR NR NR 
4.7% 
vs 
5.6% 
2.9% 
vs 
5.9% 
6% 
vs 
7.1% 
 
 
 
 
Sedentary 
 
                    
NR 
 
                     
NR 
26/72 
(36.1%) 
vs 
21/70    
(30%) 
NR 
37/52  
(71.2%) 
vs 
36/53  
(67.9%) 
195/476 
(41%) 
vs 
184/477 
(38.6%) 
NR 
58/138  
(42%) 
vs 
68/152 
(44.7%) 
171/382 
(44.8%) 
vs 
148/383 
(38.6%) 
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Occupation 
Housewife 
 
                    
NR 
 
                     
NR 
31/72 
(43.1%) 
vs 
30/70 
(42.9%) 
NR NR 
126/476 
(26.5%) 
vs 
118/477 
(24.7%) 
NR 
25/138 
(18.1%) 
vs 
33/152 
(21.7%) 
72/382 
(18.8%) 
vs 
93/383 
(24.3%) 
Active 
 
                    
NR 
 
                    
NR 
15/72 
(20.8%) 
vs 
19/70 
(27.1%) 
NR NR 
155/476 
(32.5%) 
vs 
175/477 
(36.7%) 
NR 
55/138 
(39.9%) 
vs 
51/152 
(33.6%) 
139/382 
(36.4%) 
vs 
142/383 
(37.1%) 
Daily smokers (%) 
 
                
NR 
10%  
(overall 
smoking 
index) 
16/72 
(22.2%) 
vs 
20/70 
(28.6%) 
NR 
2/52      
(3.8%) 
vs 
1/53      
(1.9%) 
NR 
11/107 
(10.3%) 
vs 
12/89  
(13.5%) 
18/138  
(13%) 
vs 
29/152 
(19.1%) 
40/382 
(10%) 
vs 
54/383 
(14.1%) 
Pre-pregnancy BMI Mean+SD 
 
NR 
 
NR 
24.3±0.5 
vs 
23.4±0.5 
24.1±4.5 
vs 
23.4±3.8 
23.8±3.8 
vs 
23.9±4.7 
23.7±3.9 
vs 
23.5±4.2 
23.8±4.4 
vs 
24.1±4.3 
24.0±4.3 
vs 
23.6±4 
23.6±3.8 
vs 
23.4±4.2 
                                                       
Pre-pregnancy BMI     (%) 
 
                    
NR 
 
                    
NR 
                        
NR 
                   
NR 
                 
NR 
<18.5 
11/480  
(2.3%)         
vs         
24/482     
<18 
1/106       
(0.9%)             
vs              
2/90      
            
NR 
<18.5 
10/382 
(2.6%)   
vs   
20/383 
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(5%) 
18.5-24.9 
323/480 
(67.3%)           
vs        
329/482 
(68.2%) 
25-29.9 
111/480 
(23.1%)       
vs         
92/482 
(19.1%) 
>30 
35/480   
(7.3%)         
vs         
37/482  
(7.7%) 
(2.2%) 
18-24.9 
73/106 
(68.9%)        
vs              
58/90   
(64.5%) 
25-29.9 
25/106 
(23.6%)        
vs            
21/90  
(23.3%) 
>30 
7/106    
(6.6%)          
vs              
9/90        
(10%) 
(5.2%) 
18.5-24.9 
258/382 
(67.5%) 
vs 
259/383 
(67.6%) 
25-29.9 
89/382 
(23.3%) 
vs   
75/383 
(19.6%) 
>30 
25/382 
(6.5%)   
vs   
29/383 
(7.6%)  
Prior PTB 
 
NR 
 
NR 
2.8% 
vs 
4.3% 
NR NR 
0% 
vs 
0% 
NR 
5.8% 
VS 
3.9% 
0% 
vs 
0% 
GA, Gestational Age; BMI, Body Mass Index; SD, Standard Deviation; WR, Week Range; NR, Not Reported. 357 
 358 
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Data are presented always in the same order: intervention group vs control group. 359 
* These data are taken from reference26 of the same authors on the very same pregnant women population. 360 
 361 
 362 
 363 
 364 
 365 
 366 
 367 
 368 
 369 
 370 
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Table 4. Primary and secondary outcomes 371 
 Carpe
nter, 
199010 
Prevedel, 
200311 
Barakat, 
200812 
Cavalcante, 
200913 
Haakst
and, 
201114 
Ruiz, 
201315 
Barakat, 
201416 
Barakat, 
201417 
Barakat, 
201618 
Total RR or MD 
(95% CI) 
 
PTB 
<37weeks 
0/7 
(0%) 
vs 
0/7 
(0%) 
3/22 
(13.6%) 
vs 
1/19 
(5.3%) 
2/72 
(2.8%) 
vs 
3/70 
(4.3%) 
2/33** 
(6.1%) 
vs 
3/37    
(8.1%) 
 
2/52 
(3.8%) 
vs 
1/53 
(1.9%) 
8/335 
(2.3%) 
vs 
2/352 
(0.6%) 
4/106 
(3.8%) 
vs 
4/91 
(4.4%) 
6/138 
(4.3%) 
vs 
11/152 
(7.2%) 
19/257 
(7.4%)§§ 
vs 
21/256 
(8.2%)§§ 
46/1022 
(4.5%) 
vs 
46/1037 
(4.4%) 
1.01 
[0.68, 1.50] 
 
GA at 
delivery     
(weeks) 
Mean + SD 
NR NR 39.57±1.
1 
vs 
39.71±1.
4 
39.2±2.2 
***  
vs 
39.1±1.6 
*** 
39.9±1
.2 
vs 
39.6±1
.2 
39.6±1.5 
vs 
39.6±1.3 
39.46±1.9 
vs 
39.2±2.2 
39.6±1.1 
vs 
39.7±1.3 
39.6 ±1.74 
vs 39.4 ±1.86 
--- 0.05  
[-0.07, 0.17] 
 
Spontaneous 
vaginal 
delivery 
NR NR 51/72 
(70.8%)*      
vs 
50/70 
(71.4%)* 
21/33   
(63.6%) 
vs 
20/37   
(54,1%) 
NR 280/335 
(83.6%) 
vs 
286/352 
(81.3%) 
72/105 
(68.6%) 
vs 
52/91  
(57.1%) 
100/138 
(72.5%)§§ 
vs 
88/152 
(57.9%)§§ 
260/382 
(68.1%) 
vs 
236/383 
(61.6%) 
784/1065 
(73.6%) 
vs 
732/1085 
(67.5%) 
1.09 [1.04, 
1.15] 
 
Operative 
vaginal 
NR NR 10/72 
(13.9%)* 
NR NR NR 15/105 
(14.3%) 
16/138 
(11.6%)§ 
49/382 
(12.8%) 
90/697 
(12.9%) 
0.78 [0.61, 
1.01] 
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delivery vs 
9/70 
(12.9%)* 
vs 
13/91  
(14.3%) 
vs 
29/152 
(19.1%)§ 
vs 
64/383 
(16.7%) 
vs 
115/696 
(16.5%) 
 
Cesarean 
delivery 
NR NR 11/72 
(15.3%)* 
vs  
11/70 
(15.7%)* 
12/33   
(36.4%) 
vs 
17/37   
(45.9%) 
NR 55/335 
(16.4%) 
vs 
66/352 
(18.7%) 
18/105 
(17.1%) 
vs 
26/91  
(28.6%) 
22/138 
(15.9%)§ 
vs  
35/152   
(23%) § 
73/382 
(19.1%) 
vs 
83/383 
(21.7%) 
191/1065 
(17.9%) 
vs 
238/1085 
(22%) 
0.82 [0.69, 
0.97] 
 
GDM NR NR NR NR NR 7/335 
(2.1%) 
vs 
18/352 
(5.1%) 
5/106 
(4.7%) 
vs 
5/90 
(5.6%) 
6/138 
(4.3%) 
vs 
12/152 
(7.9%) 
2/257 
(0.8%) 
vs 
15/256 
(5.9%) 
20/836 
(2.4%) 
vs 
50/850 
(5.9%) 
0.41 [0.24, 
0.68] 
Hypertensiv
e disorders 
NR NR NR NR 1/52 
(1.9%)  
vs 
1/53 
(1.9%) 
5/335 
(1.5%) 
vs 
20/352 
(5.7%) 
NR NR 6/257 
(2.3%) 
vs 
13/256 
(5.1%) 
12/644 
(1.9%) 
vs 
34/661 
(5.1%) 
0.36 [0.19, 
0.69] 
Birth weight 
(g) 
Mean + SD 
NR 3110 
vs 
3175 
3165±41
1 
vs 
3307±47
7 
3222.2±562.
7 
vs  
3312.7±656.
1 
3477±
424 
vs 
3542±
464 
3219±43
3 
vs 
3215±41
9 
3186.6±4
40.76 
vs 
3261.18±
466.59 
3203±461 
vs 
3232±448 
3252±438 
vs 
3218±453 
--- -10.46 [-47.1 
to 26,21] 
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LBW NR NR 4/72 
(5.6%) 
vs 
4/70 
(5.7%) 
3/33 (9.1%) 
vs 
2/37 (5.4%) 
1/52 
(1.9%) 
vs 
1/53 
(1.9%) 
19/335 
(5.7%) 
vs 
15/352 
(4.3%) 
NR NR 12/257 
(4.7%)§§ 
vs 
14/256 
(5.5%)§§ 
39/749 
(5.2%) 
vs 
36/768 
(4.7%) 
1.11 [0.72, 
1.73] 
 
GA, gestational age; LBW, low birth weight; PTB, preterm birth; GDM, gestational diabetes mellitus; Hypertensive disorders include gestational 372 
hypertension and preeclampsia  373 
Data are presented as number in the intervention group vs number in the control group with percentage 374 
* These data are taken from reference27 of the same authors on the very same pregnant women population.  375 
**Authors report that a woman in the exercise group was lost to follow up: data on her delivery and on the newborn infant are not available. 376 
***These data are taken from reference26 of the same authors on the very same pregnant women population.   377 
§ These data are taken from reference28 of the same authors on the very same pregnant women population. 378 
§§Data from only normal BMI women subgroup. 379 
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Figure 1. Flow diagram of studies identified in the systematic review. (Prisma template [Preferred Reporting Item for Systematic 381 
Reviews and Meta-analyses]) 382 
Figure 2. Assessment of risk of bias. (A) Summary of risk of bias for each trial; Plus sign: low risk of bias; minus sign: high risk of 383 
bias; question mark: unclear risk of bias. (B) Risk of bias graph about each risk of bias item presented as percentages across all 384 
included studies.  385 
Figure 3. Funnel plot for assessing publication bias in the primary outcome (i.e. incidence of preterm birth). RR, relative risk 386 
Figure 4. Forest plot for the risk of the primary outcome (i.e. incidence of preterm birth). CI, confidence interval; M-H, Mantel-387 
Haenszel; df, degrees of freedom. 388 
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